Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial.
Di Leo A, Jerusalem G, Petruzelka L, Torres R, Bondarenko IN, Khasanov R, Verhoeven D, Pedrini JL, Smirnova I, Lichinitser MR, Pendergrass K, Malorni L, Garnett S, Rukazenkov Y, Martin M. Di Leo A, et al. Among authors: garnett s. J Natl Cancer Inst. 2014 Jan;106(1):djt337. doi: 10.1093/jnci/djt337. Epub 2013 Dec 7. J Natl Cancer Inst. 2014. PMID: 24317176 Free PMC article. Clinical Trial.
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology.
Garnett SA, Martin M, Jerusalem G, Petruzelka L, Torres R, Bondarenko IN, Khasanov R, Verhoeven D, Pedrini JL, Smirnova I, Lichinitser MR, Pendergrass K, Lindemann JP, Di Leo A. Garnett SA, et al. Breast Cancer Res Treat. 2013 Feb;138(1):149-55. doi: 10.1007/s10549-012-2395-8. Epub 2013 Feb 3. Breast Cancer Res Treat. 2013. PMID: 23378064 Free PMC article. Clinical Trial.
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.
Di Leo A, Jerusalem G, Petruzelka L, Torres R, Bondarenko IN, Khasanov R, Verhoeven D, Pedrini JL, Smirnova I, Lichinitser MR, Pendergrass K, Garnett S, Lindemann JP, Sapunar F, Martin M. Di Leo A, et al. Among authors: garnett s. J Clin Oncol. 2010 Oct 20;28(30):4594-600. doi: 10.1200/JCO.2010.28.8415. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855825 Clinical Trial.
A good drug made better: the fulvestrant dose-response story.
Robertson JF, Lindemann J, Garnett S, Anderson E, Nicholson RI, Kuter I, Gee JM. Robertson JF, et al. Among authors: garnett s. Clin Breast Cancer. 2014 Dec;14(6):381-9. doi: 10.1016/j.clbc.2014.06.005. Epub 2014 Jun 24. Clin Breast Cancer. 2014. PMID: 25457991 Review.
No More Extinctions: Recovering Australia's Biodiversity.
Woinarski JCZ, Garnett ST, Legge SM. Woinarski JCZ, et al. Among authors: garnett st. Annu Rev Anim Biosci. 2024 Oct 1. doi: 10.1146/annurev-animal-111523-102004. Online ahead of print. Annu Rev Anim Biosci. 2024. PMID: 39353087 Review.
Efficacy, Safety and Acceptability of a Very-Low-Energy Diet in Adolescents with Obesity: A Fast Track to Health Sub-Study.
Gow ML, Jebeile H, House ET, Alexander S, Baur LA, Brown J, Collins CE, Cowell CT, Day K, Garnett SP, Grunseit A, Inkster MK, Kwok C, Lang S, Paxton SJ, Truby H, Varady KA, Lister NB. Gow ML, et al. Among authors: garnett sp. Nutrients. 2024 Sep 16;16(18):3125. doi: 10.3390/nu16183125. Nutrients. 2024. PMID: 39339725 Free PMC article. Clinical Trial.
No basis for claim that 80% of biodiversity is found in Indigenous territories.
Fernández-Llamazares Á, Fa JE, Brockington D, Brondízio ES, Cariño J, Corbera E, Farhan Ferrari M, Kobei D, V P, Márquez GYH, Molnár Z, Tugendhat H, Garnett ST. Fernández-Llamazares Á, et al. Among authors: garnett st. Nature. 2024 Sep;633(8028):32-35. doi: 10.1038/d41586-024-02811-w. Nature. 2024. PMID: 39232141 No abstract available.
258 results